MiniMed Group, Inc.
Research MiniMed Group, Inc. (MMED) on Bullrun: market cap USD 5.31B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerMMED
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyUSD
- Market capUSD 5.31B
- Financial periodQ2 2026
- RevenueUSD 837.00M
- Net income-USD 185.00M
- Free cash flow-USD 226.00M
- Gross margin57.3%
Valuation Snapshot
latest market cap is USD 5.31B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 5.31B | n/a | n/a | n/a |
About MiniMed Group, Inc.
MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company offers technologies including insulin delivery devices, such as insulin pumps and pens, continuous glucose monitors, other consumables, supplies, and related software and services. It serves people with diabetes who require insulin therapy, which represents all people with T1D and a subset of those with T2D.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is MiniMed Group, Inc.'s market cap?
MiniMed Group, Inc.'s market capitalization is USD 5.31B.
What does MiniMed Group, Inc. do?
MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company offers technologies including insulin delivery devices, such as insulin pumps and pens, continuous glucose monitors, other consumables, supplies, and related software and services. It serves people with diabetes who require insulin therapy, which represents all people with T1D and a subset of those with T2D.